AB-005
|
AB-005
[1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone |
|
| (1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | |
| Synthetic cannabinoids | |
| Synthetic cannabinoid receptor agonists |
|
| 895155-25-6 | |
|
|
InChI=1S/C23H32N2O/c1-22(2)21(23(22,3)4)20(26)18-15-25(19-12-7-6-11-17(18)19)14-16-10-8-9-13-24(16)5/h6-7,11-12,15-16,21H,8-10,13-14H2,1-5H3
|
|
MOBWRRIAIHYXLB-UHFFFAOYSA-N
|
|
|
O=C(C1=CN(CC2N(C)CCCC2)C3=C1C=CC=C3)C4C(C)(C)C4(C)C
|
|
| C23H32N2O | |
| 352.513 g/mol |